Sonoma Pharmaceuticals, Inc. Warrant 2016-21.01.20 on Sonoma Pharmaceuticals
(NASDAQ : SNOAW)

( )
SNOAW After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
JAZZJazz Pharmaceuticals Plc
0.49%125.932.2%$82.73m
ICPTIntercept Pharmaceuticals, Inc.
-0.34%110.8218.6%$66.95m
PRGOPerrigo Co. Plc
0.76%48.976.8%$64.89m
PTLAPortola Pharmaceuticals, Inc.
3.86%30.967.7%$46.14m
CTLTCatalent Inc
1.06%42.022.4%$42.71m
ICLRICON Plc
0.67%145.054.1%$36.06m
UTHRUnited Therapeutics Corporation
0.92%119.6314.4%$32.44m
HZNPHorizon Pharma plc
1.05%23.177.4%$30.97m
MDCOMedicines Company
3.17%24.7721.8%$27.07m
AERIAerie Pharmaceuticals, Inc.
1.66%41.756.9%$26.50m
ENDPEndo International Plc
0.48%10.578.9%$26.48m
PCRXPacira Pharmaceuticals, Inc.
2.52%40.6810.6%$21.56m
TBPHTheravance Biopharma Inc
2.30%27.569.9%$4.00m
MDWDMediWound Ltd.
0.21%4.720.6%$3.89m
SGYPSynergy Pharmaceuticals, Inc.
9.65%0.3126.3%$3.01m

Company Profile

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. It offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.